---
schema_version: "secwatch.filing_event.v1"
accession: "0001178913-25-002390"
form_type: "8-K"
ticker: "SLXN"
cik: "0002022416"
company_name: "Silexion Therapeutics Corp"
filed_at: "2025-07-16T23:59:59+00:00"
generated_at: "2026-05-18T06:20:32.173345+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Silexion Therapeutics announces 1-for-15 reverse share split to maintain Nasdaq listing

## Summary
- Reverse split effective after market close July 28; split-adjusted trading starts July 29 under ticker SLXN.
- Every 15 ordinary shares combined into 1; fractional shares rounded up to nearest whole share.
- Par value increases from $0.0009 to $0.0135 per share; no action required from shareholders.
- Split designed to regain compliance with Nasdaq minimum bid price rule (Listing Rule 5550(a)(2)).
- CEO Ilan Hadar states split supports strategic growth initiatives and capital markets positioning.

## SEC filing metadata
- accession: 0001178913-25-002390
- form_type: 8-K
- ticker: SLXN
- cik: 0002022416
- company_name: Silexion Therapeutics Corp
- filed_at: 2025-07-16T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2022416/000117891325002390/0001178913-25-002390-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2022416/000117891325002390/zk2533447.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001178913-25-002390
- JSON: https://secwatch.observer/filing/0001178913-25-002390.json
- Plain text: https://secwatch.observer/filing/0001178913-25-002390.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.